The chemokine interleukin-8 (IL-8) is secreted by enteric (T 84 ) and cervical (HeLa) epithelial cells in response to bacterial entry. Bacteria, including those that remain inside phagosomal vacuoles, e.g., Salmonella spp., and those that enter the cytoplasm, e.g., Listeria monocytogenes, stimulate this response (20) . Neither bacterial lipopolysaccharide (LPS) nor noninvasive bacteria induce an IL-8 response in these cell lines. In a recent investigation, using monolayers of human colon epithelial cell lines (T 84 , HT29, and Caco-2) as well as freshly isolated human intestinal epithelial cells, Jung et al. (35) demonstrated that infection with a variety of different invasive bacteria (Salmonella dublin, Shigella dysenteriae, Yersinia enterocolitica, L. monocytogenes, and enteroinvasive Escherichia coli) results in the coordinate expression and upregulation of a specific array of four proinflammatory cytokines, IL-8, monocyte chemotactic protein-1, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor alpha (TNF-␣). These cytokines have well-established roles in acute inflammation. IL-8 is a potent chemoattractant for polymorphonuclear leukocytes (PMNs), basophils, and T cells, and it activates several PMN functions (2, 45) .
The enterobacterium Y. enterocolitica causes a broad range of gastrointestinal syndromes, ranging from acute enteritis and enterocolitis to mesenteric lymphadenitis (8, 14) . The virulence of Y. enterocolitica is controlled by chromosomal (yst and inv) (16, 34, 41, 46) and plasmid-encoded genes. The pYV (for Yersinia virulence) plasmid directs the production of the outer membrane protein YadA and the secretion of 11 antihost proteins called Yops (for recent reviews, see the work of G. R. Cornelis [12, 13] ).
In vitro, Y. enterocolitica displays a number of properties relevant for its pathogenic character: Y. enterocolitica has the capacity to adhere to and to invade cultured mammalian epithelial cells (37, 43) and to adhere to extracellular matrix proteins. Adherence and internalization of Y. enterocolitica depend on a series of surface proteins, namely, Inv (33, 48, 61) , Ail (41, 42) , and YadA (6, 22, 32, 54, 60) .
Further virulence-associated properties are conveyed by the Yop proteins in vitro: in Yersinia pseudotuberculosis, YopE and YopH, which are both highly conserved in Y. enterocolitica (39, 40) , confer resistance to phagocytosis by macrophages (23, 25, 49, 50) . YopH is a protein tyrosine phosphatase (28) related to eukaryotic phosphatases which acts on multiple target cell proteins (5, 7, 31) . Furthermore, the tyrosine phosphatase activity of YopH inhibits the Fc-receptor-mediated oxidative burst in J774A.1 cells (4) . YopE has a contact-dependent cytotoxic effect on HeLa cells and macrophages (50, 51) , an effect which requires the presence of YopD (51) . YopD was also shown to be associated with the suppression of the oxidative burst in exogenously stimulated macrophages by Y. enterocolitica (31) . YopB may enhance virulence by suppressing the production of TNF-␣ by macrophages (3) . YpkA of Y. pseudotuberculosis, the homolog of YopO in Y. enterocolitica, contains sequence motifs found in eukaryotic Ser/Thr kinases of the PSK family and has a kinase activity (26) . The presumed action of the Yops, mainly YopH and YopE, implies that these bacterial virulence proteins function inside the target cells. The translocation of YopE and YopH to the intracellular compartments of target cells was shown to be dependent on intact yopB and yopD genes (51, 52, 56, 57) .
When invasive enteric pathogens penetrate intestinal mucosae, they evoke an inflammatory response. Data presented in the studies mentioned above demonstrated that Y. enterocolitica induces a comparatively lower level of IL-8 secretion by epithelial cells than other bacteria tested (20, 24 ) of the serotype O:9 W227 (9). A plasmid-cured isogenic derivative of strain W22703 was generated by plating the plasmidcarrying strain on MOX agar at 37ЊC (58) . Strain KNG22703 is a blaA mutant of W22703 in which the gene encoding ␤-lactamase A was replaced by the luxAB genes from Vibrio harveyi (36) . The Salmonella dublin strain was isolated by G. Wauters (Université Catholique de Louvain, Brussels, Belgium). E. coli SM10 lambda pir ϩ constructed by Miller and Mekalanos (44) or E. coli S17.1 (55) was used to deliver mobilizable plasmids into Y. enterocolitica. Strains and plasmids used are listed in Table 1 .
Bacterial growth conditions. Bacteria were routinely grown in tryptic soy broth (Oxoid, Basingstoke, England). Induction of the yop regulon and Yop protein analysis were done as described previously (10, 40) . For infection experiments, overnight cultures of Yersinia spp. were diluted to an optical density at 600 nm of 0.2 in brain heart infusion (Difco, Detroit, Mich.) and incubated for 3 h at 25ЊC. In order to gain greater reproducibility of infection, we decided in the course of this study to use aliquots of frozen stocks of bacteria. For this purpose, bacteria grown for 3 h at 25ЊC were collected by centrifugation and washed twice with sterile phosphate-buffered saline (PBS) (pH 7.4). Aliquots of bacteria corresponding to 5 ϫ 10 8 CFU were resuspended in PBS-10 mM MgCl 2 -20% glycerol (final concentration) and immediately frozen in liquid nitrogen. The survival rate after freezing and thawing, for each strain used, was determined by plating for CFU before and after freezing and was higher than 90%. In control experiments, infections with freshly cultured bacteria or frozen bacterial stocks induced essentially the same level of IL-8. Antibiotics (Boehringer, Mannheim, Germany) were used at the following final concentrations: chloramphenicol, 20 g ml Ϫ1 ; gentamicin, 40 g ml
Ϫ1
; kanamycin, 50 g ml Ϫ1 ; tetracycline, 20 g ml Ϫ1 ; and nalidixic acid, 35 g ml Ϫ1 . Cell lines. Human HeLa cervical epithelial cells (ATCC CCL 2) were obtained from the American Type Culture Collection, Rockville, Md. Human colon epithelial carcinoma T 84 cells (ATCC CCL-248) were a kind gift from the Ludwig Institute for Cancer Research, Brussels, Belgium. HeLa cells were grown in RPMI 1640 (Seromed; Biochrome Université Catholique de Louvain, KG, Berlin, Germany)-10% fetal bovine serum (Gibco BRL, Paiseley, Scotland) supplemented with 2 mM L-glutamine (Seromed) and streptomycin (100 g/ml) (Sigma Chemical Co., St. Louis, Mo.). T 84 cells were cultured in 50% Iscove's modified Dulbecco's medium-50% Ham's F12 (Gibco BRL)-5% fetal bovine serum (Gibco BRL) in the presence of streptomycin (100 g/ml). Cells were grown in a humidified 8% CO 2 atmosphere at 37ЊC.
DNA methods and cloning techniques. Plasmid DNA extraction, restriction enzyme digests, DNA ligations, and transformation of E. coli were performed by standard techniques (53) .
Construction of the yopB mutant and complementing plasmids (pEH500, pEH503, and pEH504). To mutagenize yopB we amplified the yopB gene by PCR using primers MIPA224 and MIPA124 (Fig. 1) . The 5Ј primer (MIPA224) is located upstream of yopB within lcrH (29) . The amplified fragment was cloned into pBluescriptII (KSϪ) (Stratagene, La Jolla, Calif.) cut by BamHI and SalI, yielding pPW72. Codons 89 to 217 of the yopB gene were deleted by EcoRV digestion of pPW72 and religation, giving pPW74. This mutant yopB allele was subcloned as a PvuII fragment into SmaI-digested pKNG101 (36), yielding pPW75, and exchanged with the wild-type allele of pYVe227, giving rise to pPW2275. The yopH promoter was amplified by PCR with primer YopH5 and YopHPROM (Fig. 1) . The 148-bp product was cloned into the BamHI site of pBluescriptII (KSϪ), giving rise to plasmid pPROM20. yopB, yopD, and yopBD were amplified with primers YopB5/YopB3, YopD5/YopD3, and YopB5/ YopD3, respectively ( Fig. 1) , and cloned as BamHI fragments into pBluescriptII (KSϪ). DNA fragments containing the yopB, yopD, and yopBD genes were cut out with AflIII-PstI and cloned downstream of the yopH promoter into pPROM20 digested with NcoI-PstI. The BamHI-PstI fragments containing the yopH promoter and the respective yop gene(s) were ligated into pRK404 (18) digested with Bam-PstI, resulting in plasmids pEH500, pEH503, and pEH504.
Infection protocol. Epithelial cells were seeded into 24-well culture plates (Falcon) at 1 ϫ 10 5 to 2 ϫ 10 5 cells per well in 1 ml of tissue culture medium containing 100 g of streptomycin per ml. Cells were allowed to adhere for 20 to 24 h. Viability of the cells was routinely controlled by trypan blue exclusion. One to two hours before the infection, cells were washed three times with sterile PBS (pH 7.4) and incubated in medium containing heat-inactivated fetal bovine serum without streptomycin.
Bacteria grown for 3 h in brain heart infusion at 25ЊC (see bacterial growth conditions) were collected by centrifugation and washed twice in sterile PBS. After determination of the optical density, appropriate dilutions of the bacteria in PBS were performed before infection. Cell cultures were infected with 50 to 100 l of bacterial suspension per well, at a bacterium/cell ratio of 50:1 or as indicated in the text. The actual number of bacteria administered was determined by plating 0.1 ml of 1:10 serial dilutions on tryptic soy agar plates and counting CFU after 36 h of incubation at 28ЊC.
Cells and bacteria were incubated for 2 h to allow bacterial adherence and entry. After removal of the medium, cultures were washed three times to remove extracellular bacteria and further incubated for 4 h in the presence of 40 g of gentamicin per ml to kill remaining extracellular bacteria. Culture supernatants were then removed and centrifuged for 20 min to pellet residual bacteria and cells before IL-8 determination. Cells of the monolayers were lysed in 24-well plates with 0.1% Triton X-100 in physiological saline. The number of released viable bacteria was determined by plating serial 10-fold dilutions on tryptic soy agar containing the appropriate antibiotics.
As an alternative to the use of bacterial cultures, the experiments reflected in Fig. 4 and 5 and Table 3 were done using frozen stocks of bacteria (see bacterial growth conditions) for infections. For this purpose frozen stocks were thawed on ice and centrifuged, and bacterial pellets were resuspended in PBS. Dilutions of bacteria, infections of cells, and platings for the actual inoculum were performed as described above.
TNF-␣, a gift of the Ludwig Institute for Cancer Research, and bacterial LPS from E. coli (Sigma) were used in concentrations of 5 and 100 ng/ml, respectively.
Interleukin determination by ELISA. The amount of IL-8 secreted into the supernatant was determined by an enzyme-linked immunosorbent assay (ELISA) using a human IL-8 quantikine kit from R&D Systems (Oxon, United Kingdom). The sensitivity of the ELISA was 3 pg/ml.
RESULTS

Secretion of IL-8 by epithelial cells infected with virulent or nonvirulent Y. enterocolitica.
To study the release of IL-8 by epithelial cells after infection with Y. enterocolitica, we employed two cell lines: T 84 colonic epithelial cells and HeLa cervical epithelial cells. Monolayers of T 84 and HeLa cells were infected with bacteria as described in Materials and Methods. After the initial infection period of 2 h and a further cultivation for 4 h in the presence of gentamicin, the amounts of IL-8 secreted into the supernatant were measured. As a control we included a strain of Salmonella dublin in our experiments, an invasive bacterium shown to induce IL-8 secretion by human epithelial cell lines (20) . As shown in Table 2 ϩ bacteria and determined the number of viable intracellular Yersinia organisms. We found that at the end of the culture period the numbers of intracellular pYV Ϫ bacteria were much higher than those for pYV ϩ bacteria (Fig. 2) . To analyze whether a lower rate of entry or intracellular multiplication of pYV ϩ Yersinia organisms was responsible for the phenomenon, we monitored the number of viable intracellular bacteria for 4 h after the initial infection phase. The results showed that the pYV Ϫ and the pYV ϩ strains multiplied only once or twice during this period (data not shown) and that 
Salmonella dublin
a Semiconfluent monolayers of epithelial cells in 24-well plates were infected at a bacteria/cell ratio of 50:1 as described in Materials and Methods. Bacterial entry was allowed for 2 h before cells were washed and medium containing gentamicin (40 g/ml) was added. After 4 h in culture, the supernatants were taken off and centrifuged for 2 min and the concentrations of IL-8 in the supernatants were determined. Intracellular bacterial counts were determined after lysis of the cells by plating serial dilutions.
b LPS and TNF-␣ were used at 100 and 5 ng/ml, respectively. no difference in levels of intracellular multiplication was detectable (data not shown). With respect to the pYV ϩ strain, our finding is in agreement with results of Devenish and Schiemann (17) , who reported the lack of intracellular multiplication of virulent Y. enterocolitica in HeLa cells.
These data seemed to indicate that differences in the abilities to invade HeLa cells may be the reason for the observed difference in amounts of IL-8 released. To achieve similar numbers of intracellular pYV ϩ and pYV Ϫ Yersinia organisms, we infected HeLa cells with various numbers of bacteria at multiplicities of infection of between 50 and 1,000. As depicted in Fig. 3 , at very high multiplicities of infection intracellular counts for pYV ϩ Yersinia organisms reached levels comparable to those of the pYV Ϫ strain. Surprisingly, however, there was still a significantly smaller amount of IL-8 secreted into the culture supernatant (Fig. 3) . Thus, approximately 2 ϫ 10 6 viable intracellular pYV ϩ Yersinia organisms induced a level of IL-8 secretion of 131 pg/ml while about the same number of pYV Ϫ Yersinia organisms gave rise to an amount of 546 pg/ml (Fig. 3) . Although we tried to obtain a higher number of intracellular bacteria, in particular pYV ϩ bacteria, by using a multiplicity of infection higher than 1,000, we could never obtain higher counts of intracellular Y. enterocolitica. This could indicate that under our experimental conditions, with a statistical mean of 10 to 20 bacteria per cell, the maximal possible level of infection was reached. The data presented in Fig. 3 suggested that, beside the difference in the level of invasion, a second effect, exerted by a pYV-encoded factor, is responsible for the low-level IL-8 secretion by epithelial cells infected with virulent Y. enterocolitica.
Rosqvist et al. (50) have reported that YopE is cytotoxic for cultured HeLa cells. To exclude the possibility that the reduced level of IL-8 response was due to this cytotoxic effect, we analyzed the viability of HeLa cells at the end of the experiment by trypan blue exclusion. The results showed no significant difference for cells infected with pYV ϩ or pYV Ϫ Y. enterocolitica under these conditions.
Effect of YopB and YopD on IL-8 release. To investigate if
Yop proteins are responsible for the suppression of IL-8 secretion, we monitored the IL-8 response to infection with a Yop secretion mutant. HeLa monolayers were infected with the yscK mutant KNG22703(pAA210) which is defective in the secretion of all Yop proteins (1). Infection with this strain gave rise to intracellular bacterial counts comparable to those of the pYV Ϫ strain. In addition, the amount of IL-8 secreted by HeLa cells was strongly increased above levels induced by the pYV ϩ strain: 195 pg/ml compared with 17 pg/ml (Fig. 4) .
Although the IL-8 response induced by the yscK mutant did not reach the same levels as those for the nonvirulent strain, we took this result as an indication that the suppression of IL-8 is caused by a secreted Yop(s). Subsequent analysis of yopH, yopE, and yopOP mutants (Table 1 ) revealed some variation with respect to the numbers of intracellular bacteria as well as the amounts of IL-8 secreted but did not show a strong effect on the IL-8 response (Fig. 4) . However, the yopBD mutant W22703(pGC153) induced a high level of IL-8 secretion (213 pg/ml), although the number of viable intracellular bacteria was quite low (Fig. 4) . This mutant contains a polar insertion in yopB and does not produce YopB and YopD, but it secretes all the other Yops (10). When this mutant was used to infect T 84 cells, we observed the same effect, i.e., high levels of IL-8 secretion (data not shown).
The significance of these findings for the yopBD mutant was confirmed by dose-response experiments, the results of which are shown in Fig. 5 . HeLa cells were infected with increasing doses of pYV Ϫ or pGC153 Y. enterocolitica W22703. After the culture period the numbers of viable intracellular bacteria and the IL-8 concentrations in the supernatants were determined. As depicted in Fig. 5A , an increase in the amount of starting inoculum resulted in an increase in the number of intracellular bacteria for the pYV Ϫ and the yopBD mutant strain (pGC153). However, the counts for intracellular yopBD Y. enterocolitica organisms were 5-to 10-fold lower than for the plasmidless strain. Nevertheless, infection with the yopBD mutant Y. enterocolitica stimulated high levels of IL-8 secretion (Fig. 5B) . IL-8 levels were even slightly higher than those found for comparable numbers of intracellular pYV Ϫ Y. enterocolitica (Fig. 5B) .
To exclude the possibility that the pYV plasmid derivative pGC153 of the yopBD mutant strain is less stable and that IL-8 release resulted from bacteria that had lost the plasmid during the course of the experiment, we determined the number of plasmidless bacteria at the end of the experiment. For this purpose, we took advantage of the kanamycin resistance of the mini-Mu element inserted in yopB of pGC153 (10) . Selective plating of intracellular yopBD mutant Y. enterocolitica W22703 (pGC153) on nalidixic acid or nalidixic acid and kanamycin did not reveal any significant differences in bacterial counts, indicating that pGC153 was retained during the course of the experiment.
The results described above demonstrated that YopB and/or YopD are required for the suppression of IL-8 secretion by HeLa and T 84 cells upon infection with virulent Y. enterocolitica.
To determine which of these Yops is necessary to exert the suppressive effect, we tested a mutant defective in the production of YopD. HeLa cells infected with the yopD mutant strain W22703(pEH301) (31) secreted levels of IL-8 comparable to those induced by the yopBD mutant (Table 3) . However, when we introduced pBB2, a plasmid which directs the expression of YopD from the strong yopE promoter (59), into the yopBD mutant W22703(pGC153), we could not restore the suppression of IL-8 release (data not shown), suggesting an important role for YopB in IL-8 suppression. Introduction of pBB2 into the pYV ϩ wild-type strain did not alter IL-8 suppression (data not shown).
To elucidate the contribution of YopB to IL-8 suppression, we mutagenized yopB by introducing an internal in-frame deletion into the yopB gene on the pYV plasmid by allelic exchange. The mutant strain carrying the yopB⌬ allele was deficient in the secretion of YopB, while the secretion of other Yops was not affected. After infection of HeLa cell monolayers with this strain, we detected high IL-8 concentrations in the supernatants, confirming that both YopD and YopB are required for IL-8 suppression.
In a further attempt to analyze the role of YopB and -D, we cloned the yopB, yopD, and yopBD genes under the control of the yopH promoter on a mediumcopy-number plasmid. The plasmids were introduced into the W22703(pGC153) strain, and the transconjugant strains were examined for their Yop secretion profiles. Infection of HeLa cells with the yopBD mutant complemented for YopBD (pGC153/pEH504) gave rise to an intermediate level of IL-8 secretion into the supernatant (Table 3) . Levels of IL-8 were reduced but were significantly higher than for the pYV ϩ wildtype strain. This result indicates that the cloned genes under the control of the yopH promoter were not able to complement the mutation in W2270(pGC153) entirely. Surprisingly, introduction of the yopB (pEH503) gene alone into the yopBD mutant (pGC153) also effected the induction of IL-8. The IL-8 concentrations in the supernatants were higher than for the wild-type strain but were reduced in comparison with that of the yopBD mutant (Table 3) 
a Semiconfluent monolayers of epithelial cells in 24-well plates were infected at a bacteria/cell ratio of 50:1 as described in Materials and Methods. Bacterial entry was allowed for 2 h before cells were washed and medium containing gentamicin (40 g/ml) was added. After 4 h in culture, the supernatants were taken off and centrifuged for 20 min and the concentrations of IL-8 in the supernatants were determined. Intracellular bacterial counts were determined after lysis of the cells by plating serial dilutions. mutant by YopD alone (pEH500) had no significant effect (Table 3) .
DISCUSSION
In this study we demonstrated that the amounts of IL-8 secreted by human intestinal (T 84 (20) . A correlation between the number of intracellular Y. enterocolitica organisms and the amount of IL-8 secreted was also observed in this study (Fig. 3) . Analysis of the number of intracellular bacteria in HeLa cells revealed that the pYV ϩ strain invaded to a lesser extent than the pYV Ϫ strain. It is noteworthy that the Y. enterocolitica yopE and yopH mutants did not induce a stronger IL-8 release than the wildtype strain, indicating that the cytotoxic effects of these Yops were not the reason for the detected suppression. Viabilities of HeLa cells infected with pYV ϩ or pYV Ϫ bacteria did not differ significantly, as it was determined microscopically by trypan blue exclusion, although we occasionally observed some rounding up of HeLa cells (50) in response to infection with the pYV ϩ strain. Published work suggests that the principal function of YopB and YopD is to facilitate the translocation of effector Yops across the cytoplasmic membrane of mammalian cells. This suggestion is supported by analysis of the translated protein sequences of the yopB and yopD genes, which predict the existence of transmembrane domains (29) . Translocation of YopE into HeLa cells is reduced in a yopBD mutant of Y. enterocolitica (57) as well as in a yopD mutant of Y. pseudotuberculosis (52) . In addition, the translocation of YopH-adenylate cyclase hybrid proteins is reduced in a yopBD mutant (56) . Yersinia-mediated antiphagocytosis associated with YopH is impaired in YopB and YopD mutant strains (23) . We previously reported that yopD mutants showed impaired ability to suppress the oxidative burst in stimulated bone marrow-derived macrophages in vitro (31) . Although our data did not rule out the possibility that YopD acts as a virulence determinant on its own, it is more likely that YopD acts by allowing other Yops, including YopE and YopH, to cross the host cell membrane. With respect to the suppression of IL-8, we also favor the idea that YopD and -B act by facilitating the translocation of a so-far-unidentified Yop which abrogates the secretion of IL-8 by epithelial cells. Another possibility could be that two or more Yops, translocated by a YopBD-dependent pathway, act in a synergistic fashion to block the IL-8 response.
The level of invasion of HeLa cells by the Y. enterocolitica yopBD mutant (pGC153) was 5-to 10-fold lower than for the pYV Ϫ strain. This was somehow surprising, since the role of YopB and -D in the translocation of the antiphagocytic effectors YopE and YopH has been established (52, 56, 57) . This observation points to the possibility that the internalization of Y. enterocolitica by epithelial cells is not sensitive or is less sensitive to YopE and YopH than phagocytosis by PMNs or macrophages and/or that another factor is involved in blocking the uptake. Such a blocking effect on the internalization of Y. enterocolitica by human epithelial cells has already been reported before and was ascribed to YadA (32) .
Recently, Beuscher et al. (3) reported that YopB inhibits the production of TNF-␣ by murine macrophages in vitro. YopB has sequence similarity to contact hemolysins (29) , such as IpaB of Shigella spp. Pore formation by YopB in the target cell membrane may cause suppression of TNF-␣ (3). YopB may act in a similar manner to reduce secretion of IL-8. According to this model, YopD could act in an indirect way on IL-8 secretion by translocating or inserting YopB in the host cell membrane. An intriguing question that arises from this possibility is whether there is a common pathway for the induction of IL-8 and TNF-␣ release that could be blocked by YopB.
Eckmann et al. (19) have demonstrated that IL-8 expression in human intestinal epithelial cell lines is also stimulated by the physiological agonist IL-1␤ or TNF-␣. We are currently investigating the possibility that the reduced IL-8 response level is caused by a block of the production of the physiological agonist TNF-␣.
It is not clear by what means YopB, YopD, or the putative effector Yop is delivered to the epithelial cells to suppress IL-8 secretion: by extracellularly adhering Y. enterocolitica organisms during the initial infection phase (before they are destroyed by gentamicin) or by intracellularly located Y. enterocolitica organisms in the phagosome. We also do not know whether the suppression of IL-8 secretion depends on effects on transcription and translation or an effect on its secretion. The mechanism by which the entry of bacteria leads to the release of IL-8 is presently unknown, making it difficult to speculate about the possible effects of YopB and -D on the process. The study of the functions of YopB and YopD or of the unknown effector Yop on the release of IL-8 may help to elucidate this mechanism. Further investigations should also analyze whether the suppression of IL-8 secretion is specific for mucosal epithelial cells or whether it also works on other cell types known to secrete IL-8, e.g., macrophages and T cells.
An important issue that arises from our finding is the effect on natural infections of animals or humans. It is generally accepted that Y. enterocolitica penetrates ileal epithelia via M cells overlying Peyer's patches (27) , but there are only a few reports describing invasion of Y. enterocolitica into epithelial cells of ilea. Lian et al. (38) reported early lesions, consisting of epithelial cell degeneration, at 1 to 12 h after infection of rabbits with pYV ϩ and pYV Ϫ Y. enterocolitica. This epithelial degeneration was associated with an increase in levels of PMNs in laminae propriae. Investigations of orally infected mice showed colonization of ileal mucosae by Y. enterocolitica, although to a lesser extent than that of Peyer's patches (30) . Histopathological changes like those observed in rabbits have not been described for mice, but the studies of infected mice VOL. 64, 1996 DIFFERENTIAL CELL LINE IL-8 RESPONSE TO YERSINIA ENTRY 2111
were done at relatively late time points postinfection. Another explanation for the lack of observed epithelial cell invasion by Y. enterocolitica in mice could be that the mouse model does not accurately represent invasion of intestinal epithelia by this species. In contrast, rabbits which develop diarrhea in response to infection with Y. enterocolitica (15, 47) may serve as more relevant models in this respect and may exhibit a form of infection closer to that of humans. Eckmann et al. (20, 21) have suggested that IL-8 secreted by epithelial cells is the initial signal for the acute inflammatory response that follows bacterial invasion of mucosal surfaces. IL-8 secretion in response to bacterial entry is predominantly basolateral, indicating that secreted IL-8 accumulates in mucosae underlying the epithelial cell layers where IL-8-responsive effector cells reside. The data presented here suggest that virulent Y. enterocolitica organisms have the capacity to suppress the release of IL-8, which they would induce by invading intestinal epithelia. We speculate that this ability favors Y. enterocolitica especially during the early phase of infection. Further histopathological and histoimmunological studies with experimentally infected animals are required to determine whether reduced secretion of IL-8 by infected ileal epithelial cells and subsequent reduced rates of infiltration by PMNs are of importance in the early steps of the pathology of Y. enterocolitica.
